Librede

San Diego, United States Founded: 2009 • Age: 17 yrs Acquired By Lygos
Yeast is engineered via synthetic biology for cannabinoid compound production.
Annual revenue - Latest available
Total funding - 8 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Librede

Librede is a company based in San Diego (United States) founded in 2009 was acquired by Lygos in January 2020. Librede operates in a competitive market with competitors including GSK, Avidity Biosciences, Vividion Therapeutics, Korro Bio and Sutro Biopharma, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $224.92 K (USD), Grant

    Sep 01, 2016

  • Investors
    Lygos

    & 1 more

  • Employee Count
    Not available
  • Acquired by
    Lygos

    (Jan 15, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Librede

Investors in Librede

Librede has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Lygos and HHS.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Locked Locked Locked
Green acids are produced from microbes via synthetic biology.
Locked Locked Locked
Premium access

Investor details for Librede

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Librede

Investments
Premium access

Investment portfolio details for Librede

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Librede

Premium access

Detailed financials for Librede

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Librede Comparisons

Librede Primary company
Description
Yeast is engineered via synthetic biology for cannabinoid co...
Location
San Diego, United States
Founded Year
2009
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Librede

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Librede

Librede operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Vividion Therapeutics, Korro Bio and Sutro Biopharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of pharmaceuticals and vaccines for various therapeutic areas
Locked Locked Locked
Antibody-siRNA complexes are developed for cancer treatment.
Locked Locked Locked
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Locked Locked Locked
RNA-editing technologies are provided for precision medicine applications.
Locked Locked Locked
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
Locked Locked Locked
Therapeutics for rare respiratory diseases are developed by Savara Pharma.
Premium access

Detailed competitors of Librede

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Librede

Premium access

Complete news archive for Librede

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Librede

Librede was founded in 2009.

Librede is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Eric Steen is the current CEO of Librede.

Founded in 2009 in San Diego, United States, Librede operates in the synthetic biology sector focused on drug discovery. Yeast is engineered with metabolic pathways from Cannabis Sativa to produce chemical compounds for the endocannabinoid system, targeting neurodegenerative diseases. Natural and derivative compounds are generated for pharmaceutical and nutraceutical uses, with custom formulations supported. Two products, tetrahydrocannabinol and cannabidiol, are prepared for market launch.

Librede's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Librede has 2 investors. Key investors include Lygos, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available